In a study by Zhou et al., in an ARDS model reproduced by CLP, intratracheal administration of exposed Btk siRNA one hour prior to injury resulted in a marked reduction in inflammation, apoptosis, and pulmonary oedema. This evidence concerns the gene BTK and acute respiratory distress syndrome.